Redcliffe Labs
PrivateLast Round
Series C
Sep 17, 2024
Est. Valuation
$272.3M
Total Funding Raised
$115M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Redcliffe Labs operates in Healthcare & Life Sciences and is based in Noida. Its latest recorded funding round was a Series C round in September 2024.
Redcliffe Labs is a diagnostics and precision medicine company that provides reproductive health testing, rare disease assessments, and cancer gene diagnosis, utilizing in-house technology to deliver comprehensive screening services along with counseling and clinical data management.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Patient Engagement, Healthcare Analytics, Telemedicine, E-commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redcliffe Labs Comparables
Compare Redcliffe Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healthians | 95% | |
| Pathkind Labs | 88% | |
| Medall Healthcare Pvt. Ltd. | 87% |
For institutional investors. Book with your work email.
Redcliffe Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Private Equity | Jul 6, 2022 | ||||
| Series B | May 6, 2022 | ||||
| Series A | Apr 1, 2021 | ||||
| Seed | Mar 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Redcliffe Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LetsVenture Online | Seed |
| Spark Growth Ventures | Series B, Series C |
| Impact Fund Denmark | Series C |
| Alkemi Growth Capital | Seed, Series B, Series A |
| Y Combinator | Seed |
| LC Nueva Investment Partners | Series B |
| The Investment Fund for Developing Countries (IFU) | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 20, 2026
Partnered with Roche Diagnostics India to launch a new PCOS blood test.
- Mar 20, 2026
Elecsys AMH Plus blood test for PCOS is now available.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- goes_publicOct 23, 2026
Redcliffe plans to go public through an IPO in FY30, when its revenue is projected to exceed Rs 1,200 crore.
- hiresAug 21, 2026
Redcliffe appoints healthcare veteran Ramesh Krishnan as an Independent Director to its Board, effective Aug '26, as it advances its integrated diagnostics and preventive healthcare platform in India.
- partners_withAug 14, 2026
Redcliffe and Skyroot launch India's first diagnostics and space sciences collaboration in India on Aug 14th '26, with DRIFT-1 testing dry diagnostic reagents in Low Earth Orbit for 90 days against an identical ground control to study reagent stability and performance.
- integrates_withAug 10, 2026
In Aug '26, Redcliffe, a diagnostics provider, is working towards integrating with ABDM in India.
For institutional investors. Book with your work email.
Redcliffe Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Redcliffe Labs's valuation, stock price, and market status.
Is Redcliffe Labs a public or private company?
Redcliffe Labs is a private company.
What is the current stock price of Redcliffe Labs?
Redcliffe Labs is a private company, so its shares have no public market price. Caplight tracks Redcliffe Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redcliffe Labs worth (valuation)?
Redcliffe Labs's valuation is estimated at $272.3M based on funding round data.
Can I buy Redcliffe Labs stock?
Redcliffe Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redcliffe Labs's last funding round?
Redcliffe Labs's most recent funding round was Series C on September 17, 2024.
Who are the main investors in Redcliffe Labs?
Key investors in Redcliffe Labs include Impact Fund Denmark, The Investment Fund for Developing Countries (IFU), Leapfrog Investments.
Will Redcliffe Labs IPO soon?
No public IPO plans have been announced for Redcliffe Labs.
How can I track Redcliffe Labs secondary market activity?
Caplight tracks bids, offers, and trades in Redcliffe Labs's shares on secondary markets.